PterolactamCAS# 38072-88-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 38072-88-7 | SDF | Download SDF |
PubChem ID | 181561 | Appearance | Oil |
Formula | C5H9NO2 | M.Wt | 115.1 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5-methoxypyrrolidin-2-one | ||
SMILES | COC1CCC(=O)N1 | ||
Standard InChIKey | VULIHENHKGDFAB-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C5H9NO2/c1-8-5-3-2-4(7)6-5/h5H,2-3H2,1H3,(H,6,7) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
In vitro | Heterocyclic compounds from Chrysanthemum coronarium L. and their inhibitory activity on hACAT-1, hACAT-2, and LDL-oxidation.[Pubmed: 18481011]Arch Pharm Res. 2008 May;31(5):573-8.
|
Pterolactam Dilution Calculator
Pterolactam Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 8.6881 mL | 43.4405 mL | 86.881 mL | 173.7619 mL | 217.2024 mL |
5 mM | 1.7376 mL | 8.6881 mL | 17.3762 mL | 34.7524 mL | 43.4405 mL |
10 mM | 0.8688 mL | 4.344 mL | 8.6881 mL | 17.3762 mL | 21.7202 mL |
50 mM | 0.1738 mL | 0.8688 mL | 1.7376 mL | 3.4752 mL | 4.344 mL |
100 mM | 0.0869 mL | 0.4344 mL | 0.8688 mL | 1.7376 mL | 2.172 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- [(pF)Phe4]Nociceptin(1-13)NH2
Catalog No.:BCC5778
CAS No.:380620-88-2
- CMPDA
Catalog No.:BCC6151
CAS No.:380607-77-2
- DQP 1105
Catalog No.:BCC6205
CAS No.:380560-89-4
- 187-1, N-WASP inhibitor
Catalog No.:BCC5866
CAS No.:380488-27-7
- alpha-Epoxydihydroartemisinic acid
Catalog No.:BCN5434
CAS No.:380487-65-0
- NBMPR
Catalog No.:BCC7516
CAS No.:38048-32-7
- (+)-columbianetin
Catalog No.:BCN2331
CAS No.:3804-70-4
- Tenovin-1
Catalog No.:BCC2239
CAS No.:380315-80-0
- Sulfamonomethoxine sodium
Catalog No.:BCC9157
CAS No.:38006-08-5
- 2-Amino-4'-fluorobenzophenone
Catalog No.:BCC8530
CAS No.:3800-06-4
- LM 22A4
Catalog No.:BCC6239
CAS No.:37988-18-4
- Geranylacetone
Catalog No.:BCN7567
CAS No.:3796-70-1
- Bosutinib (SKI-606)
Catalog No.:BCC1167
CAS No.:380843-75-4
- TACA
Catalog No.:BCC6564
CAS No.:38090-53-8
- Perampanel
Catalog No.:BCC1847
CAS No.:380917-97-5
- Streptomycin sulfate
Catalog No.:BCC4851
CAS No.:3810-74-0
- Brevianamide F
Catalog No.:BCN6452
CAS No.:38136-70-8
- 28-Hydroxy-3-oxoolean-12-en-29-oic acid
Catalog No.:BCN1449
CAS No.:381691-22-1
- Bephenium Hydroxynaphthoate
Catalog No.:BCC3735
CAS No.:3818-50-6
- 7,8-Dihydroxyflavone
Catalog No.:BCC6072
CAS No.:38183-03-8
- Sulindac
Catalog No.:BCC4861
CAS No.:38194-50-2
- Adrenosterone
Catalog No.:BCC4061
CAS No.:382-45-6
- Bacopaside II
Catalog No.:BCC8125
CAS No.:382146-66-9
- Coumarin VI
Catalog No.:BCN7833
CAS No.:38215-36-0
Heterocyclic compounds from Chrysanthemum coronarium L. and their inhibitory activity on hACAT-1, hACAT-2, and LDL-oxidation.[Pubmed:18481011]
Arch Pharm Res. 2008 May;31(5):573-8.
The aerial parts of Chrysanthemum coronarium L. were extracted with MeOH, and the concentrated extract was partitioned using EtOAc, n-BuOH, and H(2)O, successively. Repeated column chromatography of the EtOAc and n-BuOH fractions gave a new heterocycle, 5,5'-dibuthoxy-2,2'-bifuran (1) along with five known compounds: methyl trans-ferulate (2), prunasin (3), sambunigrin (4), Pterolactam (5), and adenosine (6), which were identified by several spectroscopic methods including NMR and MS. This paper is the first report on the isolation of these compounds from C. coronarium L. The IC(50) values of compound 1 for human Acyl-CoA:cholesterol acyltransferase (hACAT)-1 and hACAT-2 were 0.16 mM and 0.19 mM, respectively. Compound 2 inhibited low-density lipoprotein (LDL) oxidation with an IC(50) value of 7.7 microM.